Diabetes and the WHO Model List of Essential Medicines

Affiliations

Carissa F Etienne. Lancet Diabetes Endocrinol. 2022 Jan.

. 2022 Jan;10(1):21.

doi: 10.1016/S2213-8587(21)00317-X.

¹ Pan American Health Organization, Washington, DC 20034, USA. Electronic address: director@paho.org.

No abstract available

Conflict of interest statement

CFE is the director of the Pan American Health Organization.

Diabetes and the WHO Model List of Essential Medicines.
Khan FN, Hirsch IB. Khan FN, et al. Lancet Diabetes Endocrinol. 2022 Jan;10(1):16-17. doi: 10.1016/S2213-8587(21)00318-1. Lancet Diabetes Endocrinol. 2022. PMID: 34919863 No abstract available.
Diabetes and the WHO Model List of Essential Medicines.
Beran D, Besançon S, Ewen M, Gale EAM, Lazo-Porras M, Lepeska M, Lipska K, Zafra-Tanaka J, Zhaparova A, Yudkin JS. Beran D, et al. Lancet Diabetes Endocrinol. 2022 Jan;10(1):17-18. doi: 10.1016/S2213-8587(21)00323-5. Lancet Diabetes Endocrinol. 2022. PMID: 34919864 No abstract available.
Diabetes and the WHO Model List of Essential Medicines.
Danne T, Ampudia-Blasco FJ, Mathieu C. Danne T, et al. Lancet Diabetes Endocrinol. 2022 Jan;10(1):18-19. doi: 10.1016/S2213-8587(21)00322-3. Lancet Diabetes Endocrinol. 2022. PMID: 34919865 No abstract available.
Diabetes and the WHO Model List of Essential Medicines.
Unnikrishnan R, Mohan V. Unnikrishnan R, et al. Lancet Diabetes Endocrinol. 2022 Jan;10(1):19-20. doi: 10.1016/S2213-8587(21)00321-1. Lancet Diabetes Endocrinol. 2022. PMID: 34919866 No abstract available.
Diabetes and the WHO Model List of Essential Medicines.
Reddy A. Reddy A. Lancet Diabetes Endocrinol. 2022 Jan;10(1):20-21. doi: 10.1016/S2213-8587(21)00320-X. Lancet Diabetes Endocrinol. 2022. PMID: 34919867 No abstract available.